Why Saama + AWS?
Saama and Amazon Web Services (AWS), together, can help life science companies solve critical challenges, such as high volume of data and bringing therapies to market faster, with the most advanced artificial intelligence (AI) and analytics solutions within clinical development– all embedded within a scalable, SaaS-based platform backed by AWS.
Saama brings strong clinical development domain expertise, with 20+ years of experience and experts with decades of experience in key clinical functional areas such as data management, clinical operations, information technology, and more.
Saama’s platform eliminates manual, resource-intensive activities, allowing life science organizations to optimize productivity as well as gain deeper insights into patients’ behaviors and their real-time response to treatments.
And it’s not just talk. When using Saama’s platform, life science organizations have been able to:
- Reduce query identification and generation times by as much as 90% per query,
- Realize up to 50% time savings for study data transformations,
- Reduce time from data entry to analysis by more than 35%, and more.
Saama’s AI Models Are Ready Today
It takes time to accurately train new AI models. Saama has put in the work so you don’t have to.
“(SDQ) saved us an entire month. It really has had a significant impact on the first-pass quality of our clinical data and the speed through which we can move things along and make decisions.”
– Head of Data Monitoring, Top 3 Global Pharmaceutical Company
Resources
Check out Saama’s resources to learn more about how we accelerate clinical trials- intelligently.
Case Studies
Explore our customer success stories to see how Saama can accelerate your clinical trial.
Smart Data Quality Infographic
See how Saama reduces query times from 30 minutes to 3 minutes.
In The News
Saama Launches Industry’s First AI-driven Data Platform to Accelerate Clinical Development
Suite of AI-enhanced Saas solutions automates routine processes and provides a holistic view of trial operations and patient behaviors in real time.
See What Saama Has Been Up To
See for yourself what Saama has been up to, and the impact they have had on the clinical trial industry.
Women In Science
Interview With Lisa Moneymaker, CTO/CPO, Saama, in OutsourcingPharma, where she discusses her ‘atypical’ career in Pharma.
FDA’s Draft Guidance- Hit or Miss?
Saama’s Norma Rodriguez, Vice President, Global Head of Quality Assurance & Compliance, recently sat down with Clinical Trials Arena to discuss the FDA’s draft guidance for decentralized clinical trials.
Investment Reports Interview With Vivek Sharma, CEO, Saama
Vivek Sharma, CEO, Saama, discusses the challenges facing today’s clinical trials environment, Saama’s role in accelerating COVID-19 vaccine trials, and the company’s plans for the future.
